Breast Biopsy Device Market Key Highlights:
- Market Size (2024): USD 2,450 Million
- Projected Market Size (2034): USD 4,230 Million
- CAGR (2024-2034): 5.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Breast Biopsy Device Market Definition
The biologics market is an important segment of the pharmaceutical industry, which deals with the development of drugs using biological sources, such as plants, humans, animals, and microorganisms. The increasing investments in drug discovery and development are one of the major factors boosting market growth. In addition, rising health expenditure and rapid expansion of the pharmaceutical and biotechnology industries contribute to the growth of the market.
Rising emphasis on personalized and targeted therapies creates immense opportunities in the market. With the growing prevalence of chronic diseases and other genetic disorders, there is a high demand for personalized medicines and gene therapy. Therefore, various government health agencies and pharmaceutical companies are investing heavily in research and development to discover new biologics and accelerate drug development.
It is expected that North America will sustain its market dominance in the coming years. This is mainly due to its well-established healthcare and pharmaceutical industries and advancements in biotechnology. Moreover, increasing instances of chronic diseases, including cancer, and a rising focus on drug discovery are expected to fuel the market growth in Asia Pacific.
Breast Biopsy Device Market Segmentation:
By Product
- Biopsy Needle
- MRI-Guide Biopsy Systems
- Ultrasound Guided Breast Biopsy Systems
- Vacuum-Assisted Device (VAD)
- Guide Wire (Localization Wire)
- Breast Biopsy Marker
By Indication
- Complex cyst
- Solid mass
- Suspicious solid mass( fibroadenoma )
- Suspicious micro-calcifications
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
Breast Biopsy Device Market Companies:
- ARGON MEDICAL
- Becton Dickinson and Company
- C.R. Bard, Inc.
- Cook Medical Inc.
- Devicor Medical Products, Inc.
- F. Hoffmann-La Roche Ltd.,
- GE Healthcare
- Hologic, Inc.
- Leica Biosystems
- Medax Srl Unipersonale
- Planmed Oy,
- Scion Medical Technologies, LLC
- Siemens Healthier
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
